Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) active compounds. Shows potential in the synthesis of agents targeting serotonin and dopamine receptors, which are relevant for treating psychiatric disorders such as depression, anxiety, and schizophrenia. Its structural features support binding affinity and selectivity toward specific receptor subtypes, making it valuable in optimizing neuroactive drug candidates. Also explored for improving metabolic stability and blood-brain barrier penetration in novel therapeutics.